THOMAS A BUCHHOLZ to G2 Phase
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about G2 Phase.
Connection Strength
0.035
-
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget. 2016 11 01; 7(44):71660-71672.
Score: 0.035
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.